FDA Inspection 1070966 — The Methodist Hospital Research Institute

The Methodist Hospital Research Institute — FEI 3008674916

The FDA completed an inspection of The Methodist Hospital Research Institute on November 2, 2018 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 2, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Houston, TX (United States)

Citations

IDCFRDescription
1776421 CFR 212.20(e)Written QA procedures established, followed
1782221 CFR 212.50(b)(7)Complete instructions, procedures, specs
1784921 CFR 212.60(a)Testing procedures
1786321 CFR 212.60(g)(3)Complete record of all laboratory test data
1789821 CFR 212.71(c)Correction of problems
2137621 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination